Delivery Order SPE2DB22D1202-SPE2DB25FVLP3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags with a ceiling value of $7,765.88. This non-competitive delivery order, issued on September 9, 2025, represents a firm fixed-price pharmaceutical procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,569.36 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 29, 2025. This contract employs firm fixed price pricing and represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and a key distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ceftriaxone 2 GM-D5W bags with a ceiling value of $1,977.90. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a commonly used broad-spectrum antibiotic. The contract, valued at $5,210.50 with a firm fixed-price structure, is scheduled for completion by June 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,328.85 to supply Ceftriaxone 1 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. This non-competitive delivery order was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, under a firm fixed price arrangement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $5,353.10, is scheduled for completion by August 14, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,742.76 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Ceftriaxone 2 GM-D5W bags. The contract is firm fixed price with no set-aside designation, indicating competitive award. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,796.66 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of April 25, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a common antibiotic medication used across military and federal healthcare systems. This competitively awarded, non-set-aside delivery order carries a ceiling value of $8,086.70 under firm fixed pricing, with an ultimate completion date of August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,794.85 to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on September 5, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLP3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with a contract value of $4,118.65. This delivery order represents a firm fixed price procurement with an ultimate completion date of September 18, 2025, and utilizes no set-aside provisions, indicating competitive award procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract arrangement, which encompasses specialty medications, generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/17/25 |